30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 4:30 p.m. Arthrosurface commenced U.S. launch of the OVOMotion™ stemless shoulder arthroplasty system.
  • K2M received additional FDA 510(k) clearance for the MESA® Spinal System, supporting use of sagittal plane correction in idiopathic scoliosis.
  • 1:30 p.m. Catalyst OrthoScience commenced launch of its 3-Peg Glenoid implant, to be used with the CSR™ total shoulder.
Read More

Articles of Interest All Articles

Healthpoint Capital Closes $100MM for New Fund

HealthpointCapital, a private equity firm focused on musculoskeletal healthcare, announced it closed U.S. $100MM for its fourth fund. The target for Musculoskeletal Fund IV is $500MM.